Format

Send to

Choose Destination
Pract Neurol. 2019 Aug;19(4):310-315. doi: 10.1136/practneurol-2018-002137. Epub 2019 Jun 14.

Cannabis and multiple sclerosis.

Author information

1
Neurology, Morriston Hospital, Swansea, UK drgillianingram@hotmail.com.
2
Neurology, Morriston Hospital, Swansea, UK.

Abstract

Patients with multiple sclerosis have long turned to complementary therapies to manage symptoms that licensed products can only partially control. Around half of patients with multiple sclerosis admit to previous or current cannabis use for medicinal purposes and would endorse legalisation. Despite many governments worldwide relaxing regulations around medicinal cannabis, there remain many unanswered questions as to how clinicians should prescribe or recommend products, and access to pharmaceutical-grade products remains highly restricted. Here we address what adult neurologists need to know about cannabis and its use in multiple sclerosis.

KEYWORDS:

cannabis; multiple sclerosis; pain; spasticity

PMID:
31201234
DOI:
10.1136/practneurol-2018-002137
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center